Key result
Review summarizes LIMK1 and LIMK2 regulation and signaling roles in actin dynamics and human disease.
Why the study?
Recent findings have advanced the understanding of LIM domain kinase regulation mechanisms, architectural features, and implications for human health and disease.
This review provides an updated understanding of the molecular regulation and signaling of LIM domain kinases and their implications for human health.
Informs LIMK targeting strategies in disease; leaves open clinical validation and translation.
The LIM domain kinases (LIMKs) are important actin cytoskeleton regulators. These proteins, LIMK1 and LIMK2, are nodes downstream of Rho GTPases and are the key enzymes that phosphorylate cofilin/actin depolymerization factors to regulate filament severing. They therefore perform an essential role in cascades that control actin depolymerization. Signaling of the LIMKs is carefully regulated by numerous inter- and intra-molecular mechanisms. In this review, we discuss recent findings that improve the understanding of LIM domain kinase regulation mechanisms. We also provide an up-to-date review of the role of the LIM domain kinases, their architectural features, how activity is impacted by other proteins, and the implications of these findings for human health and disease.
No takes yet. Share an insight, caveat, or question.
Casanova‐Sepúlveda et al. (2024) conducted a review in LIM domain kinase regulation. This review summarizes recent findings on the regulation mechanisms, architectural features, and signaling roles of LIM domain kinases (LIMK1 and LIMK2) in actin cytoskeleton dynamics and human disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: